2-[2-carbazol-9-yl-5-[5-[4-carbazol-9-yl-3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]pyrazin-2-yl]benzene-6-id-1-yl]oxy-9-(4-methyl-2-pyridinyl)-1H-carbazol-1-ide;bis(10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenothiazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenothiazine);10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenoxazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenoxazine;tetrakis(palladium(2+));tetrakis(platinum(2+))
C304H184N32O10Pd4Pt4S4 — CID 158071842
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-carbazol-9-yl-5-[5-[4-carbazol-9-yl-3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]pyrazin-2-yl]benzene-6-id-1-yl]oxy-9-(4-methyl-2-pyridinyl)-1H-carbazol-1-ide;bis(10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenothiazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenothiazine);10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenoxazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenoxazine;tetrakis(palladium(2+));tetrakis(platinum(2+))
2-[2-carbazol-9-yl-5-[5-[4-carbazol-9-yl-3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]pyrazin-2-yl]benzene-6-id-1-yl]oxy-9-(4-methyl-2-pyridinyl)-1H-carbazol-1-ide;bis(10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenothiazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenothiazine);10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenoxazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenoxazine;tetrakis(palladium(2+));tetrakis(platinum(2+)) (PubChem CID 158071842) has the molecular formula C304H184N32O10Pd4Pt4S4 and a molecular weight of 5779.29 g/mol. Its IUPAC name is 2-[2-carbazol-9-yl-5-[5-[4-carbazol-9-yl-3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]pyrazin-2-yl]benzene-6-id-1-yl]oxy-9-(4-methyl-2-pyridinyl)-1H-carbazol-1-ide;bis(10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenothiazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenothiazine);10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenoxazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenoxazine;tetrakis(palladium(2+));tetrakis(platinum(2+)).
Molecular Properties
| Compound Name | 2-[2-carbazol-9-yl-5-[5-[4-carbazol-9-yl-3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]pyrazin-2-yl]benzene-6-id-1-yl]oxy-9-(4-methyl-2-pyridinyl)-1H-carbazol-1-ide;bis(10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenothiazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenothiazine);10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenoxazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenoxazine;tetrakis(palladium(2+));tetrakis(platinum(2+)) |
|---|---|
| PubChem CID | 158071842 |
| Molecular Formula | C304H184N32O10Pd4Pt4S4 |
| Molecular Weight | 5779.29 g/mol |
| Exact Mass | 5772.85 |
| IUPAC Name | 2-[2-carbazol-9-yl-5-[5-[4-carbazol-9-yl-3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]pyrazin-2-yl]benzene-6-id-1-yl]oxy-9-(4-methyl-2-pyridinyl)-1H-carbazol-1-ide;bis(10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenothiazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenothiazine);10-[2-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-[5-[3-[[9-(4-methyl-2-pyridinyl)-1H-carbazol-1-id-2-yl]oxy]-4-phenoxazin-10-ylbenzene-2-id-1-yl]pyrazin-2-yl]benzene-3-id-1-yl]phenoxazine;tetrakis(palladium(2+));tetrakis(platinum(2+)) |
| SMILES | Cc1ccnc(-n2c3[c-]c(Oc4[c-]c(-c5cnc(-c6[c-]c(Oc7[c-]c8c(cc7)c7ccccc7n8-c7cc(C)ccn7)c(-n7c8ccccc8c8ccccc87)cc6)cn5)ccc4-n4c5ccccc5c5ccccc54)ccc3c3ccccc32)c1.Cc1ccnc(-n2c3[c-]c(Oc4[c-]c(-c5cnc(-c6[c-]c(Oc7[c-]c8c(cc7)c7ccccc7n8-c7cc(C)ccn7)c(N7c8ccccc8Oc8ccccc87)cc6)cn5)ccc4N4c5ccccc5Oc5ccccc54)ccc3c3ccccc32)c1.Cc1ccnc(-n2c3[c-]c(Oc4[c-]c(-c5cnc(-c6[c-]c(Oc7[c-]c8c(cc7)c7ccccc7n8-c7cc(C)ccn7)c(N7c8ccccc8Sc8ccccc87)cc6)cn5)ccc4N4c5ccccc5Sc5ccccc54)ccc3c3ccccc32)c1.Cc1ccnc(-n2c3[c-]c(Oc4[c-]c(-c5cnc(-c6[c-]c(Oc7[c-]c8c(cc7)c7ccccc7n8-c7cc(C)ccn7)c(N7c8ccccc8Sc8ccccc87)cc6)cn5)ccc4N4c5ccccc5Sc5ccccc54)ccc3c3ccccc32)c1.[Pd+2].[Pd+2].[Pd+2].[Pd+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2] |
| InChI | InChI=1S/C76H46N8O4.2C76H46N8O2S2.C76H46N8O2.4Pd.4Pt/c1-47-35-37-77-75(39-47)83-59-17-5-3-15-53(59)55-31-29-51(43-67(55)83)85-73-41-49(27-33-65(73)81-61-19-7-11-23-69(61)87-70-24-12-8-20-62(70)81)57-45-80-58(46-79-57)50-28-34-66(82-63-21-9-13-25-71(63)88-72-26-14-10-22-64(72)82)74(42-50)86-52-30-32-56-54-16-4-6-18-60(54)84(68(56)44-52)76-40-48(2)36-38-78-76;2*1-47-35-37-77-75(39-47)83-59-17-5-3-15-53(59)55-31-29-51(43-67(55)83)85-69-41-49(27-33-61(69)81-63-19-7-11-23-71(63)87-72-24-12-8-20-64(72)81)57-45-80-58(46-79-57)50-28-34-62(82-65-21-9-13-25-73(65)88-74-26-14-10-22-66(74)82)70(42-50)86-52-30-32-56-54-16-4-6-18-60(54)84(68(56)44-52)76-40-48(2)36-38-78-76;1-47-35-37-77-75(39-47)83-67-25-13-7-19-57(67)59-31-29-51(43-71(59)83)85-73-41-49(27-33-69(73)81-63-21-9-3-15-53(63)54-16-4-10-22-64(54)81)61-45-80-62(46-79-61)50-28-34-70(82-65-23-11-5-17-55(65)56-18-6-12-24-66(56)82)74(42-50)86-52-30-32-60-58-20-8-14-26-68(58)84(72(60)44-52)76-40-48(2)36-38-78-76;;;;;;;;/h3*3-40,45-46H,1-2H3;3-40,45-46H,1-2H3;;;;;;;;/q4*-4;8*+2 |
| InChIKey | ZVYHKCBTGNBTID-UHFFFAOYSA-N |
| XLogP | 77.85 |
| TPSA | 367.28 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 46 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 358 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5779.29 |
| LogP ≤ 5 | 77.85 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 46 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158071842 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.